Pharmacological Neuromodulation with Intracerebroventricular Administration of Anaerobic Dopamine for Parkinson's Disease

"Brain infusion could be a new area to treat patients." Learn about anaerobic dopamine's promising phase 1 and 2 trial results from Drs. Caroline Moreau and David Devos. This highlighted research was presented during the 2024 International Congress of Parkinson’s Disease and Movement Disorders (mdscongress.org). Authors: C. Moreau, P. Odou, A. Demailly, G. Touzet, N. Reyns, J. Labreuche, A. Duhamel, C. Barthelemy, D. Lannoy, N. Carta, B. Palas, F. Marchand, B. Gouges, C. Leclerc, C. Potey, T. Ouk, K. Dujardin, S. Baigne, L. Carton, AS. Rolland, JC. Devedjian, V. Foutel, D. Deplanque, M. Fisichella, D. Devos (Lille, France). Funded by InBrain Pharma. Read the full abstract at mdsabstracts.org.